Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,153.7
-28.7 (-0.90%)

 

  • STI Straits Times Index
    3,153.7
    -28.7 (-0.90%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.0
    -9.9 (-0.62%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,979.3
    -616.3 (-2.16%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,441.8
    13.9 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,608.6
    -909.8 (-3.08%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,922.7
    -53.1 (-0.89%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,531.0M
  • Value: 1,093.1M
  • Rise: 104
  • Fall: 219
  • Unch: 451

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.009-0.001
Sembcorp Marine0.193-0.003
Renaissance United0.004-
AP Strategic0.002-
Golden Agri-Res0.265+0.010
Jiutian Chemical0.096-0.002
YZJ Shipbldg SGD1.480-0.040
Beverly JCG0.001-
Oceanus^0.036-
Genting Sing0.820-0.020

World Indices

World Indices
Name Last Change
Nasdaq 13,401.9 -350.4
HSI 27,979.3 -616.4
HSCEI 10,411.1 -240.0
Jakarta 5,922.9 -52.9
Nikkei 225 28,608.6 -909.8
SSE Comp 3,441.8 +13.8
Shanghai A 3,607.5 +14.5
Shanghai B 250.1 +0.7
KOSPI 3,209.4 -39.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EMERGENT BIOSOLUTIONS INC EMERGENT BIOSOLUTIONS
Updated on 10 May 2021 (End of trading day)
Last (USD): 59.870 Change: -1.750 High: 61.990 Remarks: -
Change (%): -2.84 Low: 59.740
Open 61.730 Yesterday's Close 61.62
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 524,028 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 5.69370 Trailing EPS (USD) e 7.22770 NAV (USD) b 28.4181
PE a 10.515 Trailing PE f 8.283 Price / NAV b 2.1068
Dividend (USD) d - Cash In Hand (USD) g 10.2266 Issued & Paid-up Shares c 53,585,500
Dividend Yield (%) d - Price / Cash In Hand g 5.854 Treasury Shares h 1,200,000
Market Cap (M) 3,208.164 Enterprise Value (M) 3,550.864
Piotroski F Score 7 Exchange Code EBS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 65.70 Free Float (%) 92.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Feb 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EMERGENT BIOSOLUTIONS INC NYSE 3,208.164 10.515 8.283 2.1068 -
Industry Pharmaceuticals: Major NYSE 120,010.503 35.140 32.689 6.3606 2.867
Local Peer JOHNSON & JOHNSON NYSE 448,389.018 30.474 29.665 6.8109 2.337
Local Peer PFIZER INC NYSE 222,345.458 23.122 23.122 - 3.831
Local Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 217,051.939 26.730 27.197 4.2961 2.162
Local Peer ABBVIE INC NYSE 205,108.543 45.019 40.154 - 4.165
Local Peer MERCK & CO INC NYSE 197,931.130 28.008 28.144 - 3.172
Local Peer ELI LILLY AND COMPANY NYSE 186,779.904 30.156 30.657 27.0748 1.516
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 144,535.271 - - 3.8435 2.857
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 135,210.877 20.983 20.983 12.9894 1.764
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 96,930.692 13.148 14.277 4.7262 5.370
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 53,520.672 131.534 31.392 1.1921 3.713
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 4,480.688 - - -11.4780 -
Local Peer ADC THERAPEUTICS SA NYSE 1,724.704 - - - -
Other Local Peers AMNEAL PHARMACEUTICALS INC (NYSE), ZYMEWORKS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 142,775.234 44.328 35.654 9.8943 2.519
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 132,253.724 9.421 9.421 1.7157 2.555
Global Peer WUXI APPTEC HKEx 523,969.522 157.872 157.872 13.6005 0.201
Global Peer HANSOH PHARMA HKEx 196,325.902 68.011 68.011 9.2631 0.232
Global Peer ROYALTY PHARMA PLC NASDAQ 25,189.077 25.834 25.834 5.2273 0.462
Global Peer CUREVAC NV NASDAQ 19,740.414 - - 22.6803 -
Global Peer VIATRIS INC NASDAQ 18,177.946 - - 0.7919 -
Global Peer INNOVENT BIO HKEx 112,445.100 - - 10.8021 -
Global Peer CANSINOBIO-B HKEx 103,928.132 - - 14.4572 -
Global Peer SINOPHARM HKEx 80,305.428 9.943 9.943 1.2018 3.224
Other Global Peers REPLIGEN CORP (NASDAQ), JUNSHI BIO (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SH PHARMA (HKEx), IMMUNITYBIO INC (NASDAQ), REMEGEN-B (HKEx), CMS (HKEx), ALLAKOS INC (NASDAQ), AKESO-B (HKEx), INNOCARE-B (HKEx), HYGEIA HEALTH (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), BAIYUNSHAN PH (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), CHINARES PHARMA (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), CHINAGRANDPHARM (HKEx), TRAD CHI MED (HKEx), HENLIUS (HKEx), SIMCERE PHARMA (HKEx), EVEREST MED-B (HKEx), OPKO HEALTH INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), HEPALINK (HKEx), QUANTERIX CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SSY GROUP (HKEx), GENERATION BIO CO (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), OCUMENSION-B (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), UNITED LAB (HKEx), CSTONE PHARMA-B (HKEx), Y-MABS THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), ANTENGENE-B (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), SCICLONE PHARMA (HKEx), CULLINAN ONCOLOGY INC (NASDAQ), PETIQ INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), TONGRENTANGCM (HKEx), NURIX THERAPEUTICS INC (NASDAQ), IMMUNOTECH-B (HKEx), Kimia Farma Tbk. (IDX), MIND MEDICINE (MINDMED) INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), AKERO THERAPEUTICS INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), ZHAOKE OPHTH-B (HKEx), TCR2 THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), PHARVARIS NV (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), IGBB (Bursa), HUA MEDICINE-B (HKEx), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SHINEWAY PHARM (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CLENE INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), Soho Global Health Tbk. (IDX), EVOLUS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), 89BIO INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), AC IMMUNE SA (NASDAQ), NEXIMMUNE INC (NASDAQ), ATHENEX INC (NASDAQ), FUSEN PHARM (HKEx), ANGION BIOMEDICA CORP (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), CODIAK BIOSCIENCES INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), DURECT CORP (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), RENEO PHARMACEUTICALS INC (NASDAQ), RACE ONCOLOGY LTD (ASX), KALA PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), TOT BIOPHARM-B (HKEx), KALEIDO BIOSCIENCES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), BSTEAD (Bursa), DAWNRAYS PHARMA (HKEx), CITIUS PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), PHARMA (Bursa), TFF PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), IP (SET), XERIS PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), TRICIDA INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), LANTERN PHARMA INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), CRESO PHARMA LTD (ASX), ANNOVIS BIO INC (NYSE American), 180 LIFE SCIENCES CORP (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), CLEARSIDE BIOMEDICAL INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), CH BIOTECH SER (HKEx), LIQUIDIA CORPORATION (NASDAQ), GALECTO INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), IMARA INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), IX Biopharma (SGX), NOXOPHARM LTD (ASX), AQUESTIVE THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), Merck Tbk. (IDX), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), NEW RAY MEDIC (HKEx), APREA THERAPEUTICS INC (NASDAQ), KOTRA (Bursa), APTORUM GROUP LIMITED (NASDAQ), EDESA BIOTECH INC (NASDAQ), NC HEALTHCARE (HKEx), PROPHASE LABS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), EXOPHARM LTD (ASX), Phapros Tbk. (IDX), AVENUE THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), PAK FAH YEOW (HKEx), CHARMACY PHAR (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), MODERN CHI MED (HKEx), ALLENA PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), BIOHLDG (Bursa), ONCOSIL MEDICAL LIMITED (ASX), PALLA PHARMA LTD (ASX), INHIBIKASE THERAPEUTICS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), NEP INTERLONG (HKEx), AGEX THERAPEUTICS INC (NYSE American), AERPIO PHARMACEUTICALS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), WAI YUEN TONG (HKEx), CNS PHARMACEUTICALS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), EXTRAWELL PHAR (HKEx), INVION LTD (ASX), MANNATECH INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), NLS PHARMACEUTICS LTD (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), SANAI HEALTH GP (HKEx), JCT (SET), PURAPHARM (HKEx), HOTH THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), ACRUX (ASX), IMMURON LIMITED (ASX), PHARMAXIS (ASX), TALI DIGITAL LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TELIGENT INC NEW (NASDAQ), SUNZEN (Bursa), VALLON PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), SINOLIFE UTD (HKEx), ISLAND PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.770
+1.30 %
10 Days --3.880
-6.09 %
20 Days --12.890
-17.72 %
Medium Term Return 3 Months --59.570
-49.87 %
6 Months --27.720
-31.65 %
1 Year --21.600
-26.51 %
Long Term Return 2 Years -+15.670
+35.45 %
3 Years -+10.140
+20.39 %
5 Years -+21.320
+55.30 %
Annualised Return Annualised --
+9.20 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 58.790 - 137.610 Change From 1 Year Low +1.080 % Change From 1 Year Low (%) +1.84
Change From 1 Year High -77.740 % Change From 1 Year High (%) -56.49
2 Years Range 39.110 - 137.610 Change From 2 Years Low +20.760 % Change From 2 Years Low (%) +53.08
Change From 2 Years High -77.740 % Change From 2 Years High (%) -56.49
5 Years Range 24.470 - 137.610 Change From 5 Years Low +35.400 % Change From 5 Years Low (%) +144.67
Change From 5 Years High -77.740 % Change From 5 Years High (%) -56.49
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
10 May 2021 61.730 61.990 59.740 59.870 524,028 -
07 May 2021 61.410 62.500 61.100 61.620 431,602 -
06 May 2021 60.000 61.880 59.900 60.850 965,187 -
05 May 2021 58.790 62.370 58.790 61.010 571,726 -
04 May 2021 60.850 61.230 58.830 59.100 929,579 -
03 May 2021 61.350 61.940 60.710 61.590 708,610 -
30 Apr 2021 61.820 63.110 60.720 60.980 996,968 -
29 Apr 2021 62.900 63.250 61.100 63.150 852,200 -
28 Apr 2021 63.190 63.430 62.000 62.050 535,628 -
27 Apr 2021 63.840 64.950 63.200 63.750 601,841 -
26 Apr 2021 62.410 64.770 62.210 63.990 857,874 -
23 Apr 2021 63.470 63.470 60.700 61.940 1,400,807 -
22 Apr 2021 63.260 64.470 61.000 63.120 1,771,535 -
21 Apr 2021 65.300 66.730 64.870 66.000 1,170,690 -
20 Apr 2021 67.020 67.500 64.870 65.620 2,105,853 -
19 Apr 2021 75.240 75.240 67.528 67.870 1,601,541 -
16 Apr 2021 74.890 77.800 74.420 77.640 493,681 -
15 Apr 2021 75.490 75.490 74.350 74.470 827,886 -
14 Apr 2021 73.520 75.728 73.336 74.470 1,202,177 -
13 Apr 2021 73.260 75.565 71.550 72.760 1,452,163 -
12 Apr 2021 77.410 77.540 75.110 75.860 626,165 -
09 Apr 2021 77.470 78.000 75.090 77.350 979,543 -
Summary
Current 2 Weeks
(27 Apr 2021 to 10 May 2021)
63.840 64.950 58.790 59.870 7,117,369 -
Previous 2 Weeks
(13 Apr 2021 to 26 Apr 2021)
73.260 75.565 58.790 63.990 12,884,207 -
4 Weeks from
(15 Mar 2021 to 12 Apr 2021)
90.820 93.240 58.790 75.860 16,182,998 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.